← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE AND ZIDOVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2018-09-07

Drug application

FDA Application #

ANDA077411

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMIVUDINE AND ZIDOVUDINE

Generic name

Lamivudine

Active ingredients

LAMIVUDINE; ZIDOVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

First approval

2018-09-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown